Willy Lensch

Willy Lensch, PhD

Lecturer on Global Health and Social Medicine, Part-time
Member, HMS Center for Bioethics
Richard A. and Susan F. Smith Campus Center

M. William Lensch, PhD, is Associate Provost for Research at Harvard University and a Lecturer (part-time) in the Department of Global Health and Social Medicine at Harvard Medical school (HMS)l. He received his PhD in Molecular and Medical Genetics from Oregon Health Sciences University where he studied hereditary bone marrow failure and leukemia predisposition syndromes at the Portland Veteran’s Administration Medical Center. Dr. Lensch is a past Fellow of the Center for Bioethics. His professional portfolio within the provost’s office spans the schools of Harvard and provides high level management/guidance for interfaculty research and educational initiatives (IFIs) in the physical, life, and social sciences. His work in bioethics includes issues related to rare diseases, genetic modification, use of human tissues in research, stem cell biology, human/animal chimeras, and the disposition of human remains in museum collections. Dr. Lensch has served in various external roles including as a gubernatorial appointee to the State of Connecticut’s Stem Cell Research Advisory Committee, a member of the Public Education Committee of the International Society for Stem Cell Research, and as Chair of the Bioethics Subcommittee of the national American Heart Association. His recognition includes multiple Certificates of Distinction in Teaching from Harvard’s Derek Bok Center for Teaching and Learning, the Staff Family Prize for Excellence in Student Advising, and HMS’s Daniel D. Federman Staff Award for Exceptional Service, the latter for his role in the founding, operation, and ongoing strategy of the Massachusetts Consortium on Pathogen Readiness (MassCPR) during the global COVID-19 pandemic.

Publications View
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
Authors: Authors: Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.
Nature
View full abstract on Pubmed
Biomechanical forces promote embryonic haematopoiesis.
Authors: Authors: Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J, Suchy-Dicey A, Yoshimoto M, Lensch MW, Yoder MC, García-Cardeña G, Daley GQ.
Nature
View full abstract on Pubmed
Broader implications of defining standards for the pluripotency of iPSCs.
Authors: Authors: Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S.
Cell Stem Cell
View full abstract on Pubmed
Cellular reprogramming and pluripotency induction.
Authors: Authors: Lensch MW.
Br Med Bull
View full abstract on Pubmed
Disease-specific induced pluripotent stem cells.
Authors: Authors: Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ.
Cell
View full abstract on Pubmed
Reprogramming of human somatic cells to pluripotency with defined factors.
Authors: Authors: Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ.
Nature
View full abstract on Pubmed
Looking into the future of cell-based therapy.
Authors: Authors: Lensch MW, West JA.
South Med J
View full abstract on Pubmed
Hemogenic endothelial progenitor cells isolated from human umbilical cord blood.
Authors: Authors: Wu X, Lensch MW, Wylie-Sears J, Daley GQ, Bischoff J.
Stem Cells
View full abstract on Pubmed
The terminology of teratocarcinomas and teratomas.
Authors: Authors: Lensch MW, Ince TA.
Nat Biotechnol
View full abstract on Pubmed
Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera.
Authors: Authors: Lensch MW, Schlaeger TM, Zon LI, Daley GQ.
Cell Stem Cell
View full abstract on Pubmed